Variant report
Variant | nsv1016185 |
---|---|
Chromosome Location | chr6:87497775-87557774 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:87533978..87535623-chr6:87543693..87545877,2 | K562 | blood: | |
2 | chr6:87494778..87497258-chr6:87499826..87502214,2 | K562 | blood: | |
3 | chr6:87494199..87497258-chr6:87499220..87502214,3 | K562 | blood: | |
4 | chr6:87533978..87535623-chr6:87543693..87545877,2 | K562 | blood: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CGA-5 | chr6:87548088-87548191 | NONHSAT113886 |
2 | lnc-CGA-5 | chr6:87547915-87548191 | NONHSAT113887 |
3 | lnc-CGA-5 | chr6:87540309-87542399 | NONHSAT113886 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs371933737 | chr6:87525400-87525401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187650346 | chr6:87525434-87525435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs192618632 | chr6:87525470-87525471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs573899744 | chr6:87525540-87525541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183018237 | chr6:87525559-87525560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs556805645 | chr6:87525567-87525568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2145050 | chr6:87525607-87525608 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs188104610 | chr6:87525656-87525657 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs370746059 | chr6:87525657-87525658 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs527344794 | chr6:87525667-87525668 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs542749564 | chr6:87525679-87525680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs527242458 | chr6:87525709-87525710 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs149905914 | chr6:87525744-87525745 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531527633 | chr6:87525762-87525763 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs549758396 | chr6:87525794-87525795 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563922575 | chr6:87528788-87528789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs76751322 | chr6:87528832-87528833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572118410 | chr6:87528864-87528865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182627912 | chr6:87528911-87528912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs200839447 | chr6:87528939-87528940 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563885143 | chr6:87528966-87528967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs143028709 | chr6:87528981-87528982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs80015409 | chr6:87528997-87528998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs567801329 | chr6:87529042-87529043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs535192833 | chr6:87529066-87529067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564202815 | chr6:87529227-87529228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs147035527 | chr6:87529236-87529237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs569037687 | chr6:87529249-87529250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201658291 | chr6:87529254-87529255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs75098410 | chr6:87529317-87529318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs73493787 | chr6:87529348-87529349 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs558024643 | chr6:87529350-87529351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs73751743 | chr6:87534610-87534611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372010291 | chr6:87534613-87534614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548871144 | chr6:87534650-87534651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs139895751 | chr6:87534702-87534703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530521136 | chr6:87534709-87534710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs62439104 | chr6:87534745-87534746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs375073357 | chr6:87534761-87534762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs570196321 | chr6:87534827-87534828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs184020239 | chr6:87534828-87534829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs188700422 | chr6:87534835-87534836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs369093693 | chr6:87534857-87534858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs113183031 | chr6:87534905-87534906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs368307276 | chr6:87535010-87535011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs557219360 | chr6:87535039-87535040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs372225291 | chr6:87535080-87535081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs146203597 | chr6:87535081-87535082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs373047735 | chr6:87535105-87535106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs148406717 | chr6:87535128-87535129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abnormal development | 18461090 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 19490664 | CNVD |
Schizophrenia | 23813976 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:87525400-87525600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr6:87525400-87525800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr6:87525600-87525800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr6:87528600-87529400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
5 | chr6:87534600-87536000 | Enhancers | Liver | Liver |
6 | chr6:87534600-87536400 | Enhancers | HepG2 | liver |
7 | chr6:87535800-87536000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
8 | chr6:87536200-87537600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
9 | chr6:87536800-87537600 | Enhancers | Fetal Intestine Large | intestine |
10 | chr6:87537600-87538200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
11 | chr6:87537800-87538000 | Enhancers | Liver | Liver |
12 | chr6:87538200-87540000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
13 | chr6:87540000-87540600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
14 | chr6:87542200-87543200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
15 | chr6:87543200-87545400 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
16 | chr6:87545200-87545800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
17 | chr6:87545200-87545800 | Enhancers | Pancreas | Pancrea |
18 | chr6:87545400-87545600 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr6:87545400-87545800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
20 | chr6:87545600-87546000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr6:87545800-87547000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
22 | chr6:87546000-87546200 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
23 | chr6:87547200-87547400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
24 | chr6:87548600-87549200 | Enhancers | H9 Cell Line | embryonic stem cell |
25 | chr6:87549000-87549400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
26 | chr6:87549000-87549400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
27 | chr6:87549000-87549400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |